Scarica l'app Stockscreener
13.57
1.72%
0.23
Dopo l'orario di chiusura:
13.57
Precedente Chiudi:
$13.34
Aprire:
$13.26
Volume 24 ore:
1.71M
Relative Volume:
0.48
Capitalizzazione di mercato:
$1.55B
Reddito:
$631.73M
Utile/perdita netta:
$-239.78M
Rapporto P/E:
-6.7178
EPS:
-2.02
Flusso di cassa netto:
$-33.45M
1 W Prestazione:
-4.97%
1M Prestazione:
-0.80%
6M Prestazione:
+28.99%
1 anno Prestazione:
-40.66%
Intervallo 1D:
$12.97
$13.58
Intervallo di 1 settimana:
$12.97
$14.43
Portata 52W:
$6.78
$24.38
10 X Genomics Inc Stock (TXG) Company Profile
Nome
10 X Genomics Inc
Settore
Industria
Telefono
(925) 401-7300
Indirizzo
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Confronta TXG con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
13.57 | 1.66B | 631.73M | -239.78M | -33.45M | -2.02 |
|
VEEV
Veeva Systems Inc
|
270.06 | 44.25B | 2.97B | 809.93M | 1.33B | 4.87 |
|
TEM
Tempus Ai Inc
|
78.12 | 13.61B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
68.52 | 12.55B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
97.70 | 7.68B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.23 | 6.45B | 906.14M | -52.62M | 89.62M | -0.3621 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-13 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | Iniziato | Leerink Partners | Outperform |
| 2024-07-22 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-07-18 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-07-10 | Downgrade | Deutsche Bank | Buy → Hold |
| 2024-06-27 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-05-01 | Downgrade | TD Cowen | Buy → Hold |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-05-10 | Iniziato | Barclays | Overweight |
| 2023-03-31 | Iniziato | Stephens | Overweight |
| 2023-02-02 | Iniziato | UBS | Neutral |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-08-18 | Downgrade | Goldman | Neutral → Sell |
| 2022-07-25 | Iniziato | Canaccord Genuity | Buy |
| 2022-07-15 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-07-15 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-09-14 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-03-15 | Iniziato | William Blair | Outperform |
| 2020-12-02 | Iniziato | Goldman | Neutral |
| 2020-09-09 | Iniziato | Morgan Stanley | Overweight |
| 2020-07-10 | Iniziato | Stifel | Buy |
| 2020-03-05 | Iniziato | Guggenheim | Buy |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-10-07 | Iniziato | BofA/Merrill | Buy |
| 2019-10-07 | Iniziato | Cowen | Outperform |
| 2019-10-07 | Iniziato | JP Morgan | Overweight |
| 2019-09-24 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
10 X Genomics Inc Borsa (TXG) Ultime notizie
Is this a good reentry point in 10x Genomics Inc.Quarterly Trade Report & Fast Moving Stock Watchlists - Newser
Detecting price anomalies in 10x Genomics Inc. with AIJuly 2025 PostEarnings & Weekly Chart Analysis and Guides - Newser
Technical analysis overview for 10x Genomics Inc. stockJuly 2025 Sector Moves & Verified Short-Term Plans - Newser
Chart based analysis of 10x Genomics Inc. trends2025 Retail Activity & Safe Entry Zone Identification - Newser
Applying big data sentiment scoring on 10x Genomics Inc.July 2025 Analyst Calls & Growth Focused Investment Plans - Newser
What the charts say about 10x Genomics Inc. todayJuly 2025 Patterns & Verified Technical Signals - Newser
Should you wait for a breakout in 10x Genomics Inc.Stop Loss & AI Driven Price Forecasts - Newser
Multi asset correlation models including 10x Genomics Inc.Market Growth Review & Low Drawdown Investment Ideas - Newser
Will earnings trigger a reversal in 10x Genomics Inc.July 2025 Recap & Expert Approved Momentum Trade Ideas - Newser
Using economic indicators to assess 10x Genomics Inc. potentialJuly 2025 Selloffs & Weekly Momentum Picks - Newser
Commit To Buy 10x Genomics At $10, Earn 20.3% Annualized Using Options - Nasdaq
Can 10x Genomics Inc. sustain earnings growthCPI Data & Weekly Top Gainers Trade List - khodrobank.com
What MACD signals say about 10x Genomics Inc.July 2025 Opening Moves & AI Based Buy/Sell Signal Reports - Newser
Visual analytics tools that track 10x Genomics Inc. performanceWeekly Market Outlook & Low Volatility Stock Suggestions - Newser
10x Genomics, Inc. (TXG) Stock Analysis: Assessing the 7.62% Potential Upside for Investors - DirectorsTalk Interviews
Is 10x Genomics Inc. stock a good pick for beginnersPortfolio Profit Report & Daily Entry Point Trade Alerts - khodrobank.com
Volume spikes in 10x Genomics Inc. stock – what they meanJuly 2025 Update & Short-Term Trading Opportunity Alerts - Newser
Trend analysis for 10x Genomics Inc. this weekJuly 2025 Snapshot & Safe Capital Allocation Plans - Newser
Analyzing drawdowns of 10x Genomics Inc. with statistical toolsJuly 2025 Final Week & Capital Protection Trading Alerts - Newser
What earnings revisions data tells us about 10x Genomics Inc.July 2025 Closing Moves & Weekly Setup with ROI Potential - Newser
Is 10x Genomics Inc. stock a buy or sellWeekly Risk Summary & Technical Analysis for Trade Confirmation - khodrobank.com
Real time alert setup for 10x Genomics Inc. performanceJuly 2025 Update & Verified Momentum Stock Watchlist - Newser
Is 10x Genomics Inc. a potential multi bagger2025 Growth vs Value & Low Drawdown Momentum Trade Ideas - khodrobank.com
Does 10x Genomics Inc. meet Warren Buffett’s criteriaTreasury Yields & Risk Managed Investment Strategies - khodrobank.com
What to do if you’re stuck in 10x Genomics Inc.2025 EndofYear Setup & Verified Trade Idea Suggestions - Newser
Is this a good reentry point in 10x Genomics IncJuly 2025 Decliners & Fast Entry Momentum Alerts - Newser
Technical signs of recovery in 10x Genomics Inc.Weekly Profit Report & Detailed Earnings Play Strategies - Newser
Should you hold or exit 10x Genomics Inc. nowTrade Analysis Summary & Detailed Earnings Play Alerts - Newser
Detecting support and resistance levels for 10x Genomics Inc.2025 Market Sentiment & Safe Entry Point Alerts - Newser
What technical models suggest about 10x Genomics Inc.’s comebackIPO Watch & Low Drawdown Investment Strategies - Newser
How sentiment analysis helps forecast 10x Genomics Inc.Treasury Yields & Technical Pattern Based Buy Signals - Newser
10x Genomics Inc. Recovers — But Is It SustainableInsider Buying & Expert Approved Momentum Trade Ideas - beatles.ru
10x Genomics Inc. stock volume spike explainedWeekly Trade Recap & Intraday High Probability Alerts - Newser
Should you wait for a breakout in 10x Genomics IncPrice Action & Risk Managed Investment Signals - Newser
Is 10x Genomics Inc. still worth holding after the dipJuly 2025 PostEarnings & Community Trade Idea Sharing Platform - Newser
Is 10x Genomics Inc. stock poised for growthWeekly Profit Report & Reliable Volume Spike Trade Alerts - Newser
Published on: 2025-08-31 12:23:27 - Newser
What are 10x Genomics Inc.’s technical support levelsQuarterly Portfolio Review & Stock Market Timing Techniques - sundaytimes.kr
Quantitative breakdown of 10x Genomics Inc. recent move2025 Volatility Report & Technical Entry and Exit Tips - Newser
What earnings revisions data tells us about 10x Genomics IncQuarterly Profit Review & Step-by-Step Swing Trade Plans - Newser
Tools to monitor 10x Genomics Inc. recovery probabilityRecession Risk & Long-Term Safe Investment Plans - Newser
10 X Genomics Inc Azioni (TXG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
10 X Genomics Inc Azioni (TXG) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Taich Adam | Chief Financial Officer |
Aug 22 '25 |
Sale |
13.79 |
22,315 |
307,657 |
309,273 |
| Hindson Benjamin J. | See Remarks |
Aug 22 '25 |
Sale |
13.79 |
7,486 |
103,209 |
440,888 |
2.53%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):